Fundación Pública Andaluza Para La Gestión De La Investigación En Sevilla
Clinical trials sponsored by Fundación Pública Andaluza Para La Gestión De La Investigación En Sevilla, explained in plain language.
-
New stitch may slash hernia risk after cancer surgery
Disease control OngoingThis study tests whether a special barbed stitch (Stratafix) is better than a standard stitch at preventing incisional hernias after large abdominal surgery in cancer patients. About 140 adults having surgery for tumors in the belly will be randomly assigned to one stitch type. T…
Phase: NA • Sponsor: Fundación Pública Andaluza para la gestión de la Investigación en Sevilla • Aim: Disease control
Last updated May 26, 2026 05:07 UTC
-
Could shorter antibiotic treatment be just as effective for dangerous blood infections?
Disease control OngoingThis study looks at whether a 7-day course of antibiotics works as well as the standard 14-day course for people with a bloodstream infection caused by Pseudomonas aeruginosa. About 300 adults who have already received 6 days of treatment will be randomly assigned to stop at 7 da…
Phase: PHASE4 • Sponsor: Fundación Pública Andaluza para la gestión de la Investigación en Sevilla • Aim: Disease control
Last updated May 26, 2026 04:35 UTC
-
Gut germs linked to transplant complication risk
Knowledge-focused OngoingThis study looks at how changes in gut bacteria and chemicals after a stem cell transplant might influence the development of graft-versus-host disease (GVHD), a serious complication. Researchers will collect stool and blood samples from 88 transplant recipients and their donors …
Sponsor: Fundación Pública Andaluza para la gestión de la Investigación en Sevilla • Aim: Knowledge-focused
Last updated May 26, 2026 04:37 UTC